A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
Recruiting · NCT06403735 · Registry updated 2024-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2024-05-08 | NCT06403735 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Jiangxi Cancer Hospital | Nanchang | China | 48 |
| Shanghai East Hospital | Shanghai | China | 11 |
| The First Affiliated Hospital of Guangdong Pharmaceutical University | Guangzhou | China | 2 |
| Yunnan Cancer Hospital | Kunming | China | 44 |